medigraphic.com
ISSN 1995-9427 (Print)

2021, Number 2

<< Back Next >>

Invest Medicoquir 2021; 13 (2)

Prognostic value of ST segment shift in lead aVR in non ST segment elevation acute coronary syndrome

García HRA, Aroche AR, Aldama PLI

Language: Spanish
References: 24
Page: 1-20
PDF size: 665.85 Kb.


ABSTRACT

Introduction: ST segment lead aVR is frequently ignored during electrocardiogram analysis, although it could be an useful prognostic tool in patients with coronary acute syndrome. Objective: To determinate the contribution of ST segment shift in lead aVR in patients with non ST segment elevation acute coronary syndrome in the ocurrence of cardiovascular adverse events. Method: Analytic longitudinal study in patients with non ST segment elevation acute coronary syndrome hospitalized in coronary care unit at Hospital Hermanos Ameijeiras and Hospital Enrique Cabrera from may 2011 to may 2017. Results: Male patients (52,9 %) with a mean age 66,0 ± 8,0 and more than two comorbidities (92,2 %) were predominant. Wide ST segment shift in lead aVR was associated to advanced Killip Kimbal class, higher troponine levels, complex coronary artery disease and worse left ventricle ejection fraction. It also was related to cardiac adverse events ocurrence. Conclusion: Wide ST segment shift in lead aVR was a sensible prognostic tool that improves prediction of cardiovascular adverse events.


REFERENCES

  1. Gaziano TA, Prabhakaran D, Gaziano JM. Repercusión global de las enfermedades cardiovasculares. En: Mann DL, Zipes DP, Libby P, Bonow RO. Tratado de Cardiología. 10ma ed. España: Elsevier; 2016.p. 1-20.

  2. Organización Mundial de la salud [Internet]. Ginebra: OMS; c2021 [actualizado 17 May 2017; citado 06 Mar 2021]. Disponible en: http://www.who.int/cardiovascular_diseases/about_cvd/es/

  3. Dirección de registros médicos y estadísticas de salud. Anuario Estadístico de Salud. Anuario Estadístico de Salud [Internet]. La Habana: MINSAP; 2019 [citado 06 Mar 2021]: 31-97 p. Disponible en: http://files.sld.cu/bvscuba/files/2019/04/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2019-ed-2020-compressed.pdf.

  4. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST. Rev Esp Cardiol [Internet]. 2015 Dic [citado 03 Mar 2021];68(12):1-64. Disponible en: http://www.revespcardiol.org/es/guia-esc-2015-sobre-el/articulo/90445376/

  5. Giugliano RP, Cannon CP, Braunwald Síndrome Coronario Agudo sin elevación del ST. En: Mann DL, Zipes DP, Libby P, Bonow RO. Tratado de Cardiología. 10ma ed. España: Elsevier; 2016.p. 1155-77.

  6. Osende OJ. Fisiopatología de la cardiopatía isquémica. Fisiología miocárdica y coronaria. Epidemiología y Fisiopatología de la cardiopatía isquémica. En: Delcán JL. Cardiopatía Isquémica. 1ra ed. Madrid; 1999.p. 97-141.

  7. Jiménez Candil J, González Mata JM, Cruz González I, Hernández Hernández J, Martín A, Pabón P, et al. Pronóstico hospitalario del síndrome coronario agudo sin elevación del segmento ST determinado por una escala de riesgo integrada por variables electrocardiográficas obtenidas al ingreso hospitalario. Rev Esp Cardiol [Internet]. 2010 Jul [citado 03 Mar 2021] ;63(7):851-5. Disponible en: http://www.revespcardiol.org/es/pronostico-hospitalario-del-sindrome-coronario/articulo/13152514/.

  8. World Medical Association Declaration of Helsinki [Internet]. Brazil: WMA; c2013 [updated 2013 Oct 19; cited 2021 Feb 18]. Available from: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

  9. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary unit. A two-year experience with 250 patients. Am J Cardiology [Internet].1967 Oct [cited 2021 Mar 05];20(4):457-64. Available from: https://linkinghub.elsevier.com/retrieve/pii/0002-9149(67)90023-9.

  10. Díaz Castro O. Síndrome coronario agudo sin elevación del ST. Estándar de calidad SEC. Proceso [Internet]. Sociedad española de Cardiología; 2017 [citado 02 Mar 2021]. 9-56 p. https://secardiologia.es/images/SEC-Excelente/SCASEST_Proceso_20170104_Final.pdf.

  11. Barrabés JA, Figueras J, Moure C, Cortadellas J, Soler-Soler J. Prognostic value of lead aVR in patients with a first non–ST- Segment elevation acute myocardial infarction. Circulation [Internet]. 2003 Aug [cited 2021 Mar 04]; 108:814–9. Available from: https://www.ahajournals.org/doi/full/10.1161/01.CIR.0000084553.92734.83?url_ver=Z39.882003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed.

  12. Kosuge M, Ebina T, Hibi K, Morita S, Endo M, Maejima N, et al. Greater ST segment elevation in lead aVR is associated with worse outcomes in patients with non ST segment elevation acute coronary syndrome. JACC [Internet]. 2011 Apr [cited 07 Mar 2021]; 57:1029-36. Available from: http://www.onlinejacc.org/content/57/14_Supplement/E974.

  13. Tamura A. Significance of lead aVR in acute coronary syndrome. World J Cardiol [Internet]. 2014 Jul [cited 2021 Mar 07];6(7): 630-7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110611/.

  14. Poll Pineda JA, Rueda Macías NM, Poll Rueda A, Linares Despaign M de J. Caracterización clinicoepidemiológica de pacientes con síndrome coronario agudo según sexo. Medisan [Internet]. 2017 Oct [citado 05 Mar 2021]; 21 (10):3007-10. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S102930192017001000002

  15. Saleem FM, Sainz BG, Caceres L FM, Roman R PA, Armas R NB, Farray MG. Caracterización del sindrome coronario agudo en el Instituto de Cardiología y Cirugía Cardiovascular, 2009-2010. Rev Cuban Cardiol [Internet]. 2010 Oct-Dic [citado 08 Mar 2021];16(4):397-406.Disponible en :http://revcardiologia.sld.cu/index.php/revcardiologia/rt/printerFriendly/209/0.

  16. Del Pino S E, Pérez del Todo JM, Quiroz J LJ, Cortes R V, Torres S N. Diferencias por sexo del síndrome coronario agudo sin elevación del segmento ST en la Unidad de Cuidados Coronarios. Rev Cuban Cardiol [Internet]. 2011 Oct-Dic [citado 02 Mar 2021];17(4):304-10.Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/81.

  17. Mauro V, Rafaelli A, Castillo Costa YB, Charask A, Fairman E, Zapata Mel LE, et al. Síndromes coronarios agudos sin elevación del segmento ST y troponina ultrasensible. ¿Es el final de la estrategia conservadora? Rev Fed Arg Cardiol [Internet]. 2018 Oct [citado 19 Feb 2021];86(5): 352-7. Disponible en: https://www.sac.org.ar/wp-content/uploads/2018/10/v86n5a07.pdf.

  18. Palau P, Núñez J, Sanchis J, Bodí V, Rumiz E, Núñez E, et al. Impacto pronóstico de una estrategia invasiva en el síndrome coronario agudo sin elevación del segmento ST según la presencia o no de disfunción sistólica. Rev Esp Cardiol [Internet]. 2010 Mar [citado 05 Mar 2021]; 63(8):915-24. Disponible en: http://www.revespcardiol.org/es/impacto-pronostico-una-estrategia-invasiva/articulo/13154082/.

  19. Nabati M, Emadi M, Mollaalipour M, Babak Bagheri, Nouraei M. ST-segment elevation in lead aVR in the setting of acute coronary syndrome [abstract]. Acta Cardiol [Internet] 2016 Feb [cited 2021 Mar 02];71(1):47-54. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=Nabati+M.+ST+segment+elevation+in+lead+aVR+in+the+setting+of+acute+coronary+syndrome.

  20. Icen YK, Donmez Y, Demirtas AO, Koca H, Ardic ML, Ko AS, et al. Ischemic changes in lead aVR is associated with left ventricular thrombus or high grade spontaneous echocontrast in patients with acute anterior myocardial infarction. Turk Kardiyol Dern Ars [Internet]. 2019 Apr [cited 2021 Feb 23];47(3):168-176.Available from: https://www.journalagent.com/pubmed/linkout.asp?ISSN=1016-5169&PMID=30982814.

  21. Kosuge M, Ebina T, Hibi K, Morita S, Endo M, Maejima N, et al. Greater ST segment elevation in lead aVR is associated with worse outcomes in patients with non ST segment elevation acute coronary syndrome. JACC [Internet]. 2011 Apr [cited 15 Feb 2021];57:1029-36.Available from: http://www.onlinejacc.org/content/57/14_Supplement/E974.

  22. Yan AT, Yan RT, Kennelly BM, Anderson Jr FA, Budaj A, López-Sendón J, et al. Relationship of ST elevation in lead aVR with angiographic findings and outcome in non ST elevation acute coronary syndrome. Am Heart J [Internet]. 2007 Jul [cited 2021 Mar 04];154(1):71-8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002-8703(07)00261-X

  23. Taglieri N, Marzocchi A, Saia F, Marrozzini C, Palmerini T, Ortolani P, et al. Short and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non ST segment elevation acute coronary syndrome. Am J Cardiol [Internet].2011 Jul [cited 2021 Mar 03];108(1);21-8. Available from: https://www.ajconline.org/article/S0002-9149(11)01139-8/fulltext.

  24. Badry MF, Elmaghraby KM, Helmy HA, Demitry SR. The added value of ST elevation in lead aVR to Clinical thrombolysis in myocardial infarction risk score in predicting the angiographic severity and extent of coronary artery disease in patients with non-ST elevation acute coronary syndrome. J Curr Med Res Prac [Internet]. 2018 May [cited 2021 Mar 03]; 3:100-5. Available from:http://jcmrp.eg.net/temp/JCurrMedResPract321004254477_114904.pdf.




2020     |     www.medigraphic.com